{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:33:47Z","timestamp":1789760027985,"version":"4.0.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10067-015-2986-y","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T04:42:29Z","timestamp":1433565749000},"page":"1317-1319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gout: cartoonized and bagatellized and still left untreated. Time to change"],"prefix":"10.1007","volume":"34","author":[{"given":"Tim L.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,7]]},"reference":[{"key":"2986_CR1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T (2010) Gout. Lancet 375:318\u2013328","journal-title":"Lancet"},{"key":"2986_CR2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"77","author":"M Doherty","year":"2012","unstructured":"Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F et al (2012) Gout: why is this curable disease so sldom cured? Ann Rheum Dis 77:1765\u20131770","journal-title":"Ann Rheum Dis"},{"key":"2986_CR3","author":"CF Kuo","year":"2014","unstructured":"Kuo CF, Grainge MJ, Mallen C, Shang W, Doherty M (2014) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204463","journal-title":"Ann Rheum Dis"},{"key":"2986_CR4","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar4524","volume":"16","author":"JA Singh","year":"2014","unstructured":"Singh JA (2014) Facilitators and barriers to adherence to rate-lowering therapy in African-Americans with gout. Arthritis Res Ther 16:R82. doi: 10.1186\/ar4524","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2986-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2986-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2986-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:42Z","timestamp":1559120262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2986-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,7]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2986"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2986-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,7]]}}}